Oliveira, M.Villagrasa, P.Ciruelos, E. M.Gavila, J.Cortegoso, A.Henao, F.Vega, E.Salvador, J.Quiroga, V.Estevez, L. G.Morales, S.Tolosa, P.Salvador, F.Gonzalez, X.Saura, C.2025-01-072025-01-072020-09-010923-7534https://hdl.handle.net/10668/27556enSOLTI-1507: A phase Ib study of ipatasertib and anti-HER2 therapy in HER2-positive advanced breast cancer with PIK3CA mutation (IPATHER)conference outputopen access10.1016/j.annonc.2020.08.4531569-8041http://www.annalsofoncology.org/article/S0923753420404491/pdf573469100351